Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

339 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.
Banfield C, Herron J, Keung A, Padhi D, Affrime M. Banfield C, et al. Among authors: herron j. Clin Pharmacokinet. 2002;41 Suppl 1:37-44. doi: 10.2165/00003088-200241001-00006. Clin Pharmacokinet. 2002. PMID: 12169045 Clinical Trial.
Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM. Affrime MB, et al. Among authors: herron jm. Chest. 2000 Dec;118(6):1538-46. doi: 10.1378/chest.118.6.1538. Chest. 2000. PMID: 11115437 Clinical Trial.
The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
Salmun LM, Herron JM, Banfield C, Padhi D, Lorber R, Affrime MB. Salmun LM, et al. Among authors: herron jm. Clin Ther. 2000 May;22(5):613-21. doi: 10.1016/S0149-2918(00)80048-X. Clin Ther. 2000. PMID: 10868558 Clinical Trial.
A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
Brannan MD, Herron JM, Reidenberg P, Affrime MB. Brannan MD, et al. Among authors: herron jm. Ann Allergy Asthma Immunol. 1998 Jan;80(1):39-44. doi: 10.1016/S1081-1206(10)62937-7. Ann Allergy Asthma Immunol. 1998. PMID: 9475565 Clinical Trial.
Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis.
Brannan MD, Herron JM, Reidenberg P, Affrime MB. Brannan MD, et al. Among authors: herron jm. Clin Ther. 1995 Jul-Aug;17(4):637-47. doi: 10.1016/0149-2918(95)80040-9. Clin Ther. 1995. PMID: 8565027 Clinical Trial.
Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.
Brannan MD, Herron JM, Affrime MB. Brannan MD, et al. Among authors: herron jm. Clin Ther. 1997 Nov-Dec;19(6):1330-9. doi: 10.1016/s0149-2918(97)80008-2. Clin Ther. 1997. PMID: 9444443 Clinical Trial.
Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
Kosoglou T, Cutler DL, Staudinger H, Herron JM. Kosoglou T, et al. Chest. 2010 Jan;137(1):115-21. doi: 10.1378/chest.09-0235. Epub 2009 Sep 11. Chest. 2010. PMID: 19749003 Clinical Trial.
Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.
Sansone-Parsons A, Krishna G, Simon J, Soni P, Kantesaria B, Herron J, Stoltz R. Sansone-Parsons A, et al. Among authors: herron j. Antimicrob Agents Chemother. 2007 Feb;51(2):495-502. doi: 10.1128/AAC.00472-06. Epub 2006 Nov 13. Antimicrob Agents Chemother. 2007. PMID: 17101682 Free PMC article.
Safety of desloratadine syrup in children.
Bloom M, Staudinger H, Herron J. Bloom M, et al. Among authors: herron j. Curr Med Res Opin. 2004 Dec;20(12):1959-65. doi: 10.1185/030079904x14148. Curr Med Res Opin. 2004. PMID: 15701213 Clinical Trial.
Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers.
Gupta S, Banfield C, Kantesaria B, Flannery B, Herron J. Gupta S, et al. Among authors: herron j. J Clin Pharmacol. 2004 Nov;44(11):1252-9. doi: 10.1177/0091270004269518. J Clin Pharmacol. 2004. PMID: 15496643 Clinical Trial.
339 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page